355
Views
5
CrossRef citations to date
0
Altmetric
Treatment

Efficacy of bronchial thermoplasty in patients with severe asthma

, MD PhD, , MD PhD, , MD, DMSc, , MD, , MD & , , MD, DMSc
Pages 216-222 | Received 01 Apr 2019, Accepted 06 Oct 2019, Published online: 18 Oct 2019

References

  • Bousquet J, Bousquet PJ, Godard P, Daures J-P. The public health implications of asthma. Bull World Health Organ 2005;83(7):548–554. PMID: 16175830.
  • Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2018. https://ginasthma.org/2018-gina-report-global-strategy-for-asthma-management-and-prevention/.
  • von Bülow A, Kriegbaum M, Backer V, Porsbjerg C. The prevalence of severe asthma and low asthma control among Danish adults. J Allergy Clin Immunol Pract 2014;2(6):759–767. PMID: 25439368. doi:10.1016/j.jaip.2014.05.005.
  • Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014;43(2):343–373. PMID: 24337046. doi:10.1183/09031936.00202013.
  • Thomson NC. Bronchial thermoplasty as a treatment for severe asthma: controversies, progress and uncertainties. Expert Review of Resp Med 2018;12(4):269–282. PMID: 29471685. doi:10.1080/17476348.2018.1444991.
  • Cox PG, Miller J, Mitzner W, Leff AR. Radiofrequency ablation of airway smooth muscle for sustained treatment of asthma: preliminary investigations. Eur Respir J 2004;24(4):659–663. PMID: 15459147 doi:10.1183/09031936.04.00054604.
  • Cox G, Thomson NC, Rubin AS, Niven RM, Corris PA, Siersted HC, Olivenstein R, Pavord ID, McCormack D, Chaudhuri R. Astma control during the year after bronchial BT. N Engl J Med 2007;356(13):1327–1337. PMID: 17392302. doi:10.1056/NEJMoa064707.
  • Castro M, Rubin AS, Laviolette M, Fiterman J, De Andrade Lima M, Shah PL, Fiss E, Olivenstein R, Thomson NC, Niven RM. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind sham-controlled clinical trial. Am J Respir Crit Care Med 2010;181(2):116–124. PMID: 19815809. doi:10.1164/rccm.200903-0354OC.
  • Pavord ID, Cox G, Thomson NC, Rubin AS, Corris PA, Niven RM, Chung KF, Laviolette M, Groups R. Safety and efficacy of bronchial BT in symptomatic, severe asthma. Am J Respir Crit Care Med 2007;176(12):1185–1191. PMID: 17901415
  • Weschler ME, Lavilette M, Rubin AS, Fiterman J, Lapa e Silva JR, Shah PL, Fiss E, Olivenstein R, Thomson NC, et al. Bronchial thermoplasty – Long term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol 2013;132:1295–1302. PMID: 23998657. doi:10.1016/j.jaci.2013.08.009.
  • Torrego A, Solá I, Munoz AM, Roqué I Figuls M, Yepes-Nunez JJ, Alonso-Coello P, Plaza V. Bronchial thermoplasty for moderate or severe persistent asthma in adults. Cochrane Database Syst Rev 2014;3:CD009910. doi:10.1002/14651858.CD009910.pub2.PMID: 24585221
  • Thomson NC, Chanez P. How effective is bronchial thermoplasty for severe asthma in clinical practice?. Eur Respir J 2017;50(2):1701140. PMID: 28860271. doi:10.1183/13993003.01140-2017.
  • Smith A, Bellinger C. Bronchial thermoplasty: a review of the evidence. Clin Pulm Med 2018;25(2):39–45. doi:10.1097/CPM.0000000000000250.
  • Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J, Wagener AH, Wagers SS, Sterk PJ, Compton C. Diagnosis and definition of severe refractory asthma: an international consensus statement from the innovative medicine initiative (IMI). Thorax 2011;66(10):910–917. PMID: 21106547. doi:10.1136/thx.2010.153643.
  • Juniper EF, O′Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14(4):902–907. PMID: 10489826. doi:10.1034/j.1399-3003.1999.14d29.x.
  • Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis 1993;147(4):832–838. PMID: 8466117. doi:10.1164/ajrccm/147.4.832.
  • Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin A-C, Plummer AL, Taylor DR. An official ATS clinical guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184(5):602–615. doi:10.1164/rccm.9120-11ST.
  • Standardization of spirometry update 1994. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107–1136. doi:10.1164/ajrccm.152.3.7663792.PMID: 7663792.
  • Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6(Suppl 16):5–40. PMID: 8499054. doi:10.1183/09041950.005s1693.
  • Pretolani M, Bergqvist A, Thabut G, Dombret M-C, Knapp D, Hamidi F, Alavoine L, Taillé C, Chanez P, Erjefält JS, et al. Effectiveness of bronchial thermoplasty in patients with severe refractory asthma: clinical and histopathologic correlations. J Allergy Clin Immunol 2017;139(4):1176–1185., PMID: 27609656. doi:10.1016/j.jaci.2016.08.009.
  • Lee J, Tay TR, Radhakrishna N, Hore-Lacy F, Mackay A, Hoy R, Dabscheck E, ÒHehir R, Hew M. Nonadherence in the era of severe asthma biologics and thermoplasty. Eur Respir J 2018;51(4):1701836. PMID: 29519922. doi:10.1183/13993003.01836-2017.
  • D’Anci KE, Lynch MP, Leas BF, Apter AJ, Bryant-Stephens T, Kaczmarek JL, Umscheid CA, Schoelles K. Effectiveness and safety of bronchial thermoplasty in management of asthma (Internet). AHRQ Publication No. 18-EHC003-EF. Rockville, MD: Agency for Healthcare Research and Quality; December 2017. www.effectivehealthcare.ahrq.http://gov/reports/final.cfm. https://doi.org/10.23970/AHRQEPCCER202 doi:. PMID: 29659226.
  • ÓReilly A, Brown I, Watchorn D, Egan JJ, Lane S. The efficacy and safety of bronchial thermoplasty in severe persistent asthma on extended follow-up. QJM. An int J Med 2018;111:155–159. PMID: 29149273 doi:10.1093/qjmed/hcx221.
  • Chernyavsky IL, Russell RJ, Saunders RM, Morris GE, Berair R, Singapuri A, Chachi L, Mansur AH, Howarth PH, Dennison P. In vitro, in silico and in vivo study challenges the impact of bronchial thermoplasty on acute airway smooth muscle mass loss. Eur Respir J 2018; 24(51):1701680. PMID: 29700102. doi:10.1183/13993003.01680-2017.
  • Bonta PI, Chanez P, Annema JT, Shah PL, Niven R. Bronchial thermoplasty in severe asthma: best practice recommendations from an expert panel. Respiration 2018;95(5):289–300. PMID:30193939. doi:10.1159/000488291.
  • Tan LD, Yoneda KY, Louie S, Hogarth DK, Castro M. Bronchial thermoplasty: a decade of experience. State of art. J Allergy Clin Immunol Pract 2019;7(1):71–80. PMID: 30193939. doi:10.1016/j.jaip.2018.08.017.
  • Zafari Z, Sadatsafavi M, Marra CA, Chen W, FitzGerald JM. Cost-effectiveness of bronchial thermoplasty, omalizumab, and standard therapy for moderate-to-severe allergic asthma. PLoS ONE 2016; 11(1):e0146003. PMID: 26751790. doi:10.1371/journal.pone.0146003.
  • Zein JG, Menegay MC, Singer ME, Erzurum SC, Gildea TR, Cicenia JC, Khatri S, Castro M, Udeh BL. Cost effectiveness of bronchial thermoplasty in patients with severe uncontrolled asthma. J Asthma 2016;53(2):194–200. PMID: 26377375. doi:10.3109/02770903.2015.1072552.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.